secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K
Filed at:   2021-09-28T23:59:59+00:00
Accession:  0001493152-21-023935
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Corbus appoints Craig Millian as Chief Operating Officer, effective Sept 27
---------------------------------------------------------------------------

- Craig Millian appointed COO effective Sept 27, 2021; previously served as Chief Commercial Officer since Feb 2019.
- Amendment to employment agreement confirms role change does not constitute 'Good Reason' for termination.
- Mr. Millian's base salary remains $400,000, eligible for annual bonus up to 40% of base salary.
- He brings 25 years of pharmaceutical commercial experience from EMD Serono, Vertex, Pfizer, and Sanofi.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000149315221023935/0001493152-21-023935-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000149315221023935/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-023935

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer